| Hosting Organization |
 |
 |
| Operating Organization |

Foreign Experts Databank
of SAFEA-Dalian Biotechnological and Medical Experts Subdivision
BIT Lifesciences, Inc. |
| Supporting Organization |
 |
| International Marketing Partner |
 |
|
Participants List
(Academia) |
National Yang-Ming University, Taiwan
Abyad Medical Center and Middle-East Longevity Institute, Lebanon
Akershus University Hospital, Norway
Aligarh M University, India
American University of Beirut, USA
Antwerp University Hospital, Belgium
Applied Proteomics and Molecular Medicine, USA
Aristotelian University of Thessaloniki, Greece
Banaras Hindu University, India
Barrow Neurological Institute, USA
Baylor College of Medicine, USA
Ben-Gurion University of the Negev, Israel
Boston University School of Medicine, USA
Cancer Research Technology, UK
CHDI Foundation, California
Chinese Academy of Sciences, China
CRG-Centre de Regulaci Genmica, Spain
CSIRO Molecular and Health Technologies, Australia
Duke University, USA
Emory University, USA
exas Southern University, USA
Florida A&M University, USA
Global Pathology Support, The Netherlands
Gujarat AIDS Awareness and Prevention Unit, India
Haematopoietic Stem Cell Laboratory, UK
Harvard Medical School, USA
Hospital S Hospital S Joao, Portugal
Human BioMolecular Re-. search Institute, USA
Indiana University School of Medicine, USA
Indiana University School of Medicine, USA
Innsbruck Medical University, Austria
Institute of Experimental Pharmacology, Slovak
Instituto De Biologia Experimentale Tecnologica, Portugal
Karolinska Institutet, Sweden
Keystone College Academia, USA
McGill University, Canada
Mercer University, USA
National Center for Toxicological Research, USA
National Institutes of Health, USA
Netherlands Cancer Institute, The Netherlands
New York Medical College, USA
Osaka University, Japan
Paul-Ehrlich-Institute, Germany
Penn State College of Medicine, USA
Pennsylvania State University College of Medicine, USA
Pharmacology Temple University, USA
Scientific Advisory Board Tolerx, USA
Shanghai Unviversity of Traditional Chinese Medicine, China
Solid Tumor Working Party, Italy
Stanford University, USA
Structural Genomics Consortium Karolinska Institutet, Sweden
Tabriz University of Medical Sciences, Iran
Technion - Israel Institute of Technology Rappaport Institute, Israel
The Babraham Institute, UK
The Hebrew University, Israel
The Institute of Cancer Research, UK
The University of Queensland, Australia
The University of Sydney, Australia
The University of Texas, USA
UC College of Medicine, USA
Universidade Federal Fluminense, Brazil
University Clinic Bonn, Germany
University of Basel, Switzerland
University of British Columbia, Canada
University of California, USA
University of California-San Francisco, USA
University of Camerino, Italy
University of Cape Town, USA
University of Colorado Health Sciences Center, USA
University of Crete, Greece
University of Geneva, Switzerland
University of Heidelberg, Germany
University of Hong Kong, China
University of Maryland School of Pharmacy, USA
University of Maryland, USA
University of Massachusetts Medical School, USA
University of Miami School of Medicine, USA
University of Miami, USA
University of Miami, USA
University of Oklahoma Health Sciences Center, USA
University of Siena, Italy
University of Southern Denmark, Denmark
University of Texas at Dallas, USA
University of Texas Health Science Center, USA
University of Texas Medical, USA
University of the Sciences in Philadelphia, USA
University of Utah School of Medicine, USA
University of Western Australia, Australia
Utah State University, USA
Virginia Commonwealth University, USA
University of Gothenburg, Sweden
|
Participants List
(Business) |
3 P Biopharmaceuticals, USA
Abbott Laboratories, USA
Adolor Corporation, USA
Affimed Therapeutics AG, Germany
AILERON Therapeutics, USA
Algorithme Pharma Inc., Canada
Allon Therapeutics Inc., USA
Alpha Cancer Technologies Inc., USA
Alpha-2 Pharmaceutica AB, Israel
Amgen, Inc., USA
Arena Pharmaceuticals, USA
Astellas Pharma Inc, Japan
Astellas Pharmaceutical Inc., Japan
AstraZeneca Pharmaceuticals, USA
AstraZeneca R&D Molndal, Sweden
Astrazeneca R&D Sodertolje, Sweden
AstraZeneca, UK
AstraZeneca, USA
AuxoCell Laboratories, Inc., USA
Avexa Ltd, Australia
Bayer HealthCare, USA
Bayer Schering Pharma AG, Germany
BellBrook Labs, LLC, USA
Biological Mimetics, Inc., USA
BioPerspectives, USA
Biota Holdings Limited, USA
Boehringer Ingelheim Pharmaceuticals, Inc., USA
Bristol-Myers Squibbs, USA
Centocor/Johnson & Johnson, USA
Chemistry Forma Therapeutics, Inc., Singapore
Coley Pharmaceutical GmbH, Germany
Cordex Pharma, Inc., USA
Cornerstone Pharmaceuticals, USA
Covidien, USA
Daiichi Sankyo Pharma Development, Japan
deCODE Chemistry, USA
DxS Ltd, USA
Eisai Co., Ltd., Japan
Elan Pharmaceuticals, USA
Europe GlaxoSmithKline R&D, UK
Genentech, USA
Genetix Ltd, UK
genscript, USA
Genzyme Pharmaceuticals, USA
Gilead Sciences Benzothiadiazine Hepatitis C NS5B, USA
Hoffmann-La Roche, Switzerland
ICON PLC, USA
IDDC Corporation, USA
Idera Pharmaceuticals, USA
Jesus College, England
Johnson & Johnson Pharmaceutical, USA
Johnson & Johnson Research Pty Limited, Australia
Laboratory Cellular Technology Ltd., USA
Lundbeck Research, USA
Mallinckrodt, Inc., USA
MDS Pharma Services, USA
Medimmune, UK
Merck & Co. Inc, USA
Merck & Co., Italy
Merck and Co., Inc., China
Merck KGaA, Germany
Merck Research Laboratories, USA
Nerviano Medical Sciences, Italy
Novartis Institutes for Biomedical Research, USA
Novartis Institutes, Switzerland
Novartis Pharmaceuticals Corporation, USA
Novartis, China
Ocimum Biosolutions, India
Ondokuz Mayis University, Turkey
OphthalmoPharma, Switzerland
Pfizer, USA
Pharmanet Development Group, Inc., USA
PharmaNet, Inc., USA
Ranbaxy Laboratories Limited, India
Reaction Biology Corporation, USA
RegPak BioPharma Consulting, The Netherlands
Sanofi Aventis, USA
Schering Plough Research Institute, USA
Schlich & Co, UK
Scott & White, USA
Sequoia Pharmaceuticals Inc., USA
SeraCare Life Sciences, USA
Shanghai Biochip Co., Ltd, China
Shenogen Pharma Group, China
Siena Biotech S.p.A. A company, USA
Simulations Plus, Inc., USA
Synta Pharmaceuticals Corp, USA
TEVA Pharmaceuticals, USA
The Takeda Oncology Company, USA
ThromboGenics, USA
Transgene, France
US Oncology Research, Inc., USA
Vaxinnate, USA
Wyeth Research, USA
XOMA (US) LLC, USA
Zeptosens C a Division of Bayer (Schweiz) AG, Switzerland
Zhejiang Hisun Pharmaceutical Co., Ltd, China
Tehran University of Medical Sciences , Iran
|
|
 |
|
 |
WCG 2009
(December 1-7, 2009, Foshan, China) |
 |
ICC 2009
(Dec. 5-7, 2009, Shanghai, China) |
 |
ICA 2010
(March 24-26, 2010, Beijing, China) |
 |
WCV 2010
(March 24-26, 2010, Beijing, China) |
 |
SEB 2010
(Apr. 22-24, 2010, Shanghai, China) |
|
|
|
| 2009 Poster Abstracts |
|
There will be an exhibition of posters at the conference and the abstracts of accepted posters will be published in the conference program. You will be notified if your abstract has been accepted for poster presentation as soon as it has been reviewed by the organizing committee. All accepted posters will be presented at Poster Viewing Session during the conference. Posters will be reviewed for oral presentation 4-6 weeks prior to the conference. Oral presenters will be notified via email or telephone at least 3 weeks before the conference. The selected presenters will be posted on the agenda.
Materials to hang your posters with will be available at the poster area. Set up time TBA. You will receive your poster number 4-6 weeks prior to the conference.
Your presence near it is kindly requested during lunches and coffee breaks for discussion.
Poster abstracts format
Posters will be judged during the conference. You are invited to submit an poster abstract on the following themes of the conference for presentation in poster format. Posters submitted should be based upon original / ongoing research. Abstracts should be submitted electronically, by 20 September 2009 to: sean@iddst.com
Abstracts must be submitted electronically. They should be in the following format:
• Title in block capitals
• Author (s) and principal affiliations, with the presenting author named first
• Abstract text, of not more than 500 words, you may include the objective/purpose, method, results, and conclusion. Additionally the presenter should prepare some copies of the paper and name card, which can be distributed to the participants for keeping contact.
• A list of references is optional (no more than 5)
Poster Instructions: Guidelines
• The regular poster size is 70cm wide x 90cm high.
• The text must be typed in single line spacing in black using less than 12 pitch character to ensure that the visitors can see clearly outside 1.5 meters.
• You may display your poster from 22nd October to 24th October, 2009.
Posters’ hanging and taking down schedule
The Congress provides one board for each poster presenter, who should be aware that the poster installation and tear off are their own duties.
October 21 |
Morning |
Afternoon |
installation |
|
17:00-18:00 |
October 22-24 |
Morning |
Afternoon |
installation |
8:30-9:00 |
13:30-14:00 |
tear off |
13:00-13:30 |
17:30-18:00 |
Presentation Topic:
1. Title program headings:
2. Diseases Clinical & Research
3. Epidemiology, Prevention and Diagnosis
4. New Technology & Approaches in Drug Discovery
5. Drug Discovery and Development
6. Biological Medicine
7. Patients Palliative Care and the Public
8. Enabling Infrastructure and Resources
Please fill out all fields. Maximum characters: 2500
Remark: For Poster Registration Only
1. If attending to our conference, the registration is for poster exhibition, not across to the other program, welcome banquet, meals and social event. The abstract of poster shall embody into the proceeding of conference; we shall provide the space for poster exhibition, excluding poster making.
2. If not attending to our conference, the abstract of poster shall embody into the proceeding of conference; we shall provide the space for poster exhibition, including poster making.
Please PRINT THE POSTER including the names of the authors and the title.
|
|